HEAL - PT. Medikaloka Hermina Tbk

Rp 1.385

-25 (-2,00%)

JAKARTA – The performance of PT Medikaloka Hermina Tbk (HEAL), the managing company of Hermina Hospital network, reportedly improved in the first nine months (9M) of 2024 compared to 9M 2023, with inpatient surgeries covered 60.30% of total revenue.

Based on Q3 202 Report quoted Friday (25/10), the issuer booked revenue increase of 18.84% year-on-year (yoy) to IDR 5.02 trillion from IDR 4.22 trillion seen in the same period in 2023.

Then, hospital segment brought in IDR 4.88 trillion, up from IDR 4.11 trillion, while non-hospital revenue clocked up to IDR 139.59 billion, also up from IDR 113.43 billion.

The gross profit of this company arrived at IDR 1.87 trillion, increasing 21.53% yoy from IDR 1.54 trillion, boosting the margin up to 37.38% from 36.55%.

Its operating profit also showed an increase to IDR 866.07 billion in Q3 2024, or up 35.46% yoy from IDR 639.34 billion in Q3 2023.

In line with this number, the company recorded net profit for the year of IDR 597.35 billion until Q3 2024, up 35.29% yoy from IDR 441.50 billion, with net profit attributable to the parent entity up 34.20% yoy to IDR 468.16 billion from IDR 348.84 billion. (LK/ZH)